Last reviewed · How we verify
Flavonil® Cream
Flavonil® Cream is a Small molecule drug developed by University of Roma La Sapienza. It is currently FDA-approved.
At a glance
| Generic name | Flavonil® Cream |
|---|---|
| Sponsor | University of Roma La Sapienza |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pain and Bleeding in Subjects With Acute Anal Fissure: Comparative Evaluation of Three Treatments (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flavonil® Cream CI brief — competitive landscape report
- Flavonil® Cream updates RSS · CI watch RSS
- University of Roma La Sapienza portfolio CI
Frequently asked questions about Flavonil® Cream
What is Flavonil® Cream?
Flavonil® Cream is a Small molecule drug developed by University of Roma La Sapienza.
Who makes Flavonil® Cream?
Flavonil® Cream is developed and marketed by University of Roma La Sapienza (see full University of Roma La Sapienza pipeline at /company/university-of-roma-la-sapienza).
What development phase is Flavonil® Cream in?
Flavonil® Cream is FDA-approved (marketed).
Related
- Manufacturer: University of Roma La Sapienza — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing